Item 5.07 Submission of Matters to a Vote of Security Holders.

On September 30, 2021, Sanara MedTech Inc. (the "Company") held its 2021 Annual Meeting of Shareholders (the "Annual Meeting"). A total of 5,249,172 shares of the Company's common stock were present in person or represented by proxy at the Annual Meeting. The matter submitted for a vote and the related results are set forth below. A more detailed description of the proposal was included in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission (the "SEC") on August 30, 2021, as supplemented by the Company's Proxy Statement Supplement filed with the SEC on September 13, 2021.

Proposal 1: Election of (i) Ronald T. Nixon, (ii) J. Michael Carmena, (iii) Robert A. DeSutter, (iv) Sara N. Ortwein, (v) Ann Beal Salamone, (vi) James W. Stuckert and (vii) Kenneth E. Thorpe to the Company's Board of Directors, each to serve for a one-year term until the annual meeting of shareholders to be held in 2022 or until his or her successor is elected and qualified.





                        Votes          Votes
Nominee                Cast For      Withheld
Ronald T. Nixon        5,248,772           400
J. Michael Carmena     5,246,472         2,700
Robert A. DeSutter     5,226,455        22,717
Sara N. Ortwein        5,246,180         2,992
Ann Beal Salamone      5,246,380         2,792
James W. Stuckert      5,225,820        23,352
Kenneth E. Thorpe      5,226,483        22,689

The proposal described above was acted upon by the Company's shareholders at the Annual Meeting and received a sufficient number of votes to be approved.






2

© Edgar Online, source Glimpses